Artículos relacionados
Inmunoterapia
Therapeutic approach reinforced by tarlatamab plus durvalumab and other agents in aggressive cancers.
Artículos relacionados
Therapeutic approach reinforced by tarlatamab plus durvalumab and other agents in aggressive cancers.